The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study
- Conditions
- Enlarged Pores
- Interventions
- Device: Fractional picosecond 1064 nm laser
- Registration Number
- NCT04471948
- Lead Sponsor
- Mahidol University
- Brief Summary
The objective of this study is to evaluate the safety and efficacy of 1064-nm Picosecond laser 1064 With Microlens Array for Pore tightening.
- Detailed Description
The Safety and Efficacy of Picosecond laser 1064 Nanometers With Microlens Array for Pore tightening; a Pilot Study Primary outcome : pore size Secondary outcome : side effect, patient satisfaction, global evaluation the patient recieved laser treament once a month for 3 months and then follow up after last treatment at 1, 3 ,6 month
Enlarged facial pores is one of the skin signs in photoaging. There are 3 major clinical causes of enlarged facial pores: highs sebum excretion, decreased elasticity around pores and increased hair follicle volume. Possible causative factors of enlarged facial pores include many exogenous and endogenous factors include genetic predisposition, seborrhea and chronic ultraviolet light exposure. Picosecond laser are new device which has been used in skin rejuvenation. The main mechanism of action is laser induced optical breakdown (LIOB).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 26
- Both male and female age 25-40 years
- No underlying disease
- History of retinoid or other keratolytic drugs used within 6 months before enrolled
- History of keloid
- photosensitivity
- Immunocompromised host
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Fractional picosecond laser 1,064 nm laser Fractional picosecond 1064 nm laser 1 arm The subjects with enlarged pores were treated with fractional picosecond laser 1,064 nm laser
- Primary Outcome Measures
Name Time Method Change in pore size by Antera 3D image change from baseline in pore size at 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Dermatology, Siriraj Hospital, Mahidol University
🇹ðŸ‡Bangkok, Thailand